Philip Bufler

7.5k total citations · 1 hit paper
88 papers, 4.3k citations indexed

About

Philip Bufler is a scholar working on Immunology, Epidemiology and Surgery. According to data from OpenAlex, Philip Bufler has authored 88 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 22 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Philip Bufler's work include Psoriasis: Treatment and Pathogenesis (13 papers), IL-33, ST2, and ILC Pathways (11 papers) and Immune Response and Inflammation (11 papers). Philip Bufler is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), IL-33, ST2, and ILC Pathways (11 papers) and Immune Response and Inflammation (11 papers). Philip Bufler collaborates with scholars based in Germany, United States and Australia. Philip Bufler's co-authors include Charles A. Dinarello, Marcel F. Nold, Claudia A. Nold‐Petry, Brent E. Palmer, Soohyun Kim, Jarod A. Zepp, Tania Azam, Leonid L. Reznikov, Fabia Gamboni-Robertson and Sibylle Koletzko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Immunology.

In The Last Decade

Philip Bufler

81 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-37 is a fundamental inhibitor of innate immunity

2010 676 citations Marcel F. Nold, Claudia A. Nold‐Petry et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Bufler Germany	31	2.3k	1.2k	634	555	505	88	4.3k
Marcel F. Nold Australia	32	2.5k 1.1×	1.5k 1.2×	548 0.9×	540 1.0×	582 1.2×	71	4.5k
Claudia A. Nold‐Petry Australia	29	2.1k 0.9×	1.2k 1.0×	499 0.8×	479 0.9×	501 1.0×	67	4.0k
Joshua D. Milner United States	41	3.1k 1.3×	772 0.6×	512 0.8×	496 0.9×	534 1.1×	124	5.3k
Timothy R. D. J. Radstake Netherlands	39	2.5k 1.0×	1.3k 1.1×	470 0.7×	356 0.6×	669 1.3×	174	5.4k
Giuliana Guggino Italy	40	2.5k 1.1×	1.1k 0.9×	746 1.2×	338 0.6×	694 1.4×	158	5.1k
Hans J. P. M. Koenen Netherlands	38	3.5k 1.5×	738 0.6×	624 1.0×	449 0.8×	800 1.6×	122	5.4k
J. Michelle Kahlenberg United States	39	2.7k 1.1×	1.7k 1.4×	438 0.7×	744 1.3×	364 0.7×	127	4.9k
Sophie Hüe France	32	3.0k 1.3×	751 0.6×	965 1.5×	304 0.5×	476 0.9×	83	5.3k
Jan Dutz Canada	43	3.1k 1.3×	835 0.7×	615 1.0×	954 1.7×	455 0.9×	160	6.1k
Giuseppe Murdaca Italy	39	1.9k 0.8×	563 0.5×	578 0.9×	371 0.7×	516 1.0×	145	4.4k

Countries citing papers authored by Philip Bufler

Since Specialization

Citations

This map shows the geographic impact of Philip Bufler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bufler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bufler more than expected).

Fields of papers citing papers by Philip Bufler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Bufler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bufler. The network helps show where Philip Bufler may publish in the future.

Co-authorship network of co-authors of Philip Bufler

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Bufler. A scholar is included among the top collaborators of Philip Bufler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Bufler. Philip Bufler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schiller, Brigitte, Elisa Wirthgen, Frank Weber, et al.. (2024). Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection. European Journal of Pediatrics. 183(8). 3277–3288. 2 indexed citations

Danyel, Magdalena, Benno Kohlmaier, Christoph J. Mache, et al.. (2023). Biallelic known and novel DCDC2 variants in cholestatic liver disease: Phenotype–genotype observations in four children. Liver International. 43(5). 1089–1095. 3 indexed citations

Heuberger, Julian, et al.. (2023). Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity. Frontiers in Immunology. 14. 1261666–1261666. 2 indexed citations

Sattler, Arne, Julia Thumfart, Eva Schrezenmeier, et al.. (2022). SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation. Transplant International. 35. 10677–10677. 6 indexed citations

Hudert, Christian, Stephan Henning, & Philip Bufler. (2020). Autoimmune Lebererkrankungen bei Kindern und Jugendlichen. 15(4). 327–339.

Schunck, Wolf‐Hagen, Michael Rothe, Birgit Rudolph, et al.. (2020). Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 164. 102229–102229. 11 indexed citations

Holle, Johannes, Alexander Gratopp, Verena Varnholt, et al.. (2019). Single-Pass Albumin Dialysis in the Treatment of Children with Liver Failure. Blood Purification. 49(1-2). 55–62. 6 indexed citations

McNamee, Eóin N., Joanne C. Masterson, Paul Jedlicka, et al.. (2011). Interleukin 37 expression protects mice from colitis. Proceedings of the National Academy of Sciences. 108(40). 16711–16716. 271 indexed citations

Boraschi, Diana, Davide Lucchesi, Stefan Hainzl, et al.. (2011). IL-37: a new anti-inflammatory cytokine of the IL-1 family. European Cytokine Network. 22(3). 127–147. 299 indexed citations

10.

Werkstetter, Katharina, Susanne Bechtold‐Dalla Pozza, Birgit Filipiak‐Pittroff, et al.. (2011). Long-Term Development of Bone Geometry and Muscle in Pediatric Inflammatory Bowel Disease. The American Journal of Gastroenterology. 106(5). 988–998. 36 indexed citations

11.

Marcos, Verónica, Philipp Latzin, Andreas Hector, et al.. (2010). Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases. Respiratory Research. 11(1). 32–32. 35 indexed citations

12.

Sharma, Sheetal, Marcel F. Nold, Ralph Gräf, et al.. (2008). The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines. The Journal of Immunology. 180(8). 5477–5482. 196 indexed citations

13.

Reznikov, Leonid L., Joel Waksman, Tania Azam, et al.. (2004). Effect of advanced glycation end products on endotoxin-induced TNF-a, IL-1b and IL-8 in human peripheral blood mononuclear cells. Clinical Nephrology. 61(5). 324–336. 44 indexed citations

14.

Azam, Tania, Daniela Novick, Philip Bufler, et al.. (2003). Identification of a Critical Ig-Like Domain in IL-18 Receptor α and Characterization of a Functional IL-18 Receptor Complex. The Journal of Immunology. 171(12). 6574–6580. 26 indexed citations

15.

Reznikov, Leonid L., Soohyun Kim, Philip Bufler, et al.. (2002). The Combination of Soluble IL-18R α and IL-18R β Chains Inhibits IL-18-Induced IFN- γ. Journal of Interferon & Cytokine Research. 22(5). 593–601. 24 indexed citations

16.

Kim, Soohyun, Tania Azam, Daniela Novick, et al.. (2002). Identification of Amino Acid Residues Critical for Biological Activity in Human Interleukin-18. Journal of Biological Chemistry. 277(13). 10998–11003. 53 indexed citations

17.

Griese, Matthias, et al.. (2002). Changes of exhaled nitric oxide during steroid treatment of childhood asthma. European Respiratory Journal. 19(6). 1015–1019. 114 indexed citations

18.

Bufler, Philip, et al.. (2001). Dumping syndrome: a common problem following Nissen fundoplication in young children. Pediatric Surgery International. 17(5-6). 351–355. 56 indexed citations

19.

Griese, Matthias, et al.. (1997). Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. European Respiratory Journal. 10(9). 1989–1994. 18 indexed citations

20.

Stelter, Felix, Martin Bernheiden, Robert Smail Jack, et al.. (1996). The Myeloid Differentiation Antigen CD14 is N‐ and O‐Glycosylated. European Journal of Biochemistry. 236(2). 457–464. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact